Search

Your search keyword '"bile acids"' showing total 1,269 results

Search Constraints

Start Over You searched for: Descriptor "bile acids" Remove constraint Descriptor: "bile acids" Publication Type News Remove constraint Publication Type: News
1,269 results on '"bile acids"'

Search Results

1. Bylvay(R) (odevixibat) data shows sustained improvement in severe itch and serum bile acid levels in patients with PFIC and ALGS

2. Dr. Reddy's Laboratories launches drug to treat chronic constipation

4. European Commission Grants Orphan Drug Designation for Vivet Therapeutics Gene Therapy Product for the Treatment of Cerebrotendinous Xanthomatosis (CTX)

9. Reports from Rutgers University - The State University of New Jersey Advance Knowledge in Toxicology (Effects of Therapeutically Approved Individual Bile Acids on The Development of Metabolic Dysfunction-Associated Steatohepatitis a Low Bile ...)

11. Ipsen's Kayfanda approved for Alagille syndrome in EU

12. Ipsen's Kayfanda approved for Alagille syndrome in EU

13. European Commission Grants Orphan Drug Designation for Vivet Therapeutics Gene Therapy Product for the Treatment of Cerebrotendinous Xanthomatosis CTX

15. Department of Surgery Researchers Broaden Understanding of Cholecystectomy (Bile acid diarrhoea and metabolic changes after cholecystectomy: a prospective case-control study)

16. Vivet Therapeutics receives Orphan Drug Designation from European Commission for VTX-806

17. Vivet Therapeutics receives Orphan Drug Designation from European Commission for VTX-806

19. Orsini Now Dispensing Livdelzi (seladelpar), for Treatment of Rare Liver Disease

20. Orsini Now Dispensing Livdelzi (seladelpar), for Treatment of Rare Liver Disease

21. NGM Bio Announces $122 Million Series A Financing to Initiate Registrational Trial in Primary Sclerosing Cholangitis and Fund Phase 2 Trial in Hyperemesis Gravidarum

24. 33690000-3 Various Medicines (hematological Control Material Certified Multi-parameter Para 12 Extend: 1 X 2.5 Ml (1 Standard); Reagent 'm-30d Diluent' 20 L; Chart Tape With Thermal Recording/h/l 49x2

26. Recent Studies from National Institute of Immunology Add New Data to Colitis (A hepatocyte-specific transcriptional program driven by Rela and Stat3 exacerbates experimental colitis in mice by modulating bile synthesis)

27. Researchers' Work from Institute for Cancer Research and Treatment (IRCCS) Focuses on Nutrition Therapy [Possible Role of Tauroursodeoxycholic Acid (TUDCA) and Antibiotic Administration in Modulating Human Gut Microbiota in Home Enteral ...]

28. State Key Laboratory Researcher Provides Details of New Studies and Findings in the Area of Pruritus (Research Progress of Cholestatic Liver Disease-Related Pruritus in Chinese Medicine and Western Medicine)

30. Findings on Fisheries Research Reported by Investigators at Wageningen University and Research Center [Effect of Carbohydrate Source, Feeding Level (Restricted Vs. Satiation) and Their Combination On Nutrient Digestibility, Bile Acid Balance, ...]

31. Cholangiocyte glycocalyx degradation boosts primary sclerosing cholangitis

32. Research Study Findings from Chinese Academy of Sciences Update Understanding of Lactobacillus delbrueckii (* * Lactobacillus delbrueckii* * Ameliorated Blood Lipids via Intestinal Microbiota Modulation and Fecal Bile Acid Excretion in a ...)

33. Researchers Submit Patent Application, 'Bile Acid Metabolites For Diagnosing And Treating Depressive Disorders', for Approval (USPTO 20240183845)

34. Study Results from GlaxoSmithKline plc Broaden Understanding of Pruritus (Serum Bile Acid Change Correlates With Improvement In Pruritus In Patients With Primary Biliary Cholangitis Receiving Linerixibat)

40. Patent Issued for Bile acids and use in disease treatment (USPTO 11980645)

41. Findings on Cardiomyopathies Detailed by Investigators at Peking University (Inhibition of Fatty Acid Uptake By Tgr5 Prevents Diabetic Cardiomyopathy)

43. Mirum Announces Publication of Phase 3 MARCH Data in The Lancet Demonstrating Benefits of LIVMARLI (maralixibat) in patients with PFIC

44. DETAILED STRUCTURE OF BITTER TASTE RECEPTOR REVEALED

45. Why Organovo shares are surging today?

46. Defence Therapeutics Awarded Broad U.S. Patent Covering

47. Supply Of Bile Acid Test With Control Level 2 3 (q3) Qty : 1

49. Supply Of Medicines

50. MSU, PSU REDEFINE GUT MICROBE BENEFITS FROM BILE SALTS

Catalog

Books, media, physical & digital resources